Literature DB >> 26958922

Novel Functions of the Human Papillomavirus E6 Oncoproteins.

Nicholas A Wallace1, Denise A Galloway1.   

Abstract

Human papillomaviruses (HPVs) infect the epidermis as well as mucous membranes of humans. They are the causative agents of anogenital tract and some oropharyngeal cancers. Infections begin in the basal epithelia, where the viral genome replicates slowly along with its host cell. As infected cells begin to differentiate and progress toward the periphery, the virus drives proliferation in cells that would otherwise be quiescent. To uncouple differentiation from continued cellular propagation, HPVs express two oncoproteins, HPV E6 and E7. This review focuses on high-risk α-HPV E6, which in addition to supporting viral replication has transforming properties. HPV E6 promotes p53 degradation and activates telomerase, but the multifaceted oncoprotein has numerous other functions that are highlighted here.

Entities:  

Keywords:  p53; telomerase; tumorigenesis

Mesh:

Substances:

Year:  2015        PMID: 26958922     DOI: 10.1146/annurev-virology-100114-055021

Source DB:  PubMed          Journal:  Annu Rev Virol        ISSN: 2327-056X            Impact factor:   10.431


  23 in total

Review 1.  DNA damage response is hijacked by human papillomaviruses to complete their life cycle.

Authors:  Shi-Yuan Hong
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

Review 2.  [Invasion and metastasis mechanism of human papillomavirus in head and neck squamous cell carcinomas].

Authors:  Guang-Xue Cui; Xiao-Lei Gao; Xin-Hua Liang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-10-01

Review 3.  Cervical cancer in Ethiopia: a review of the literature.

Authors:  Awoke Derbie; Daniel Mekonnen; Endalkachew Nibret; Eyaya Misgan; Melanie Maier; Yimtubezinash Woldeamanuel; Tamrat Abebe
Journal:  Cancer Causes Control       Date:  2022-10-15       Impact factor: 2.532

4.  A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.

Authors:  Felix A Ebner; Carolin Sailer; Daniela Eichbichler; Jasmin Jansen; Anna Sladewska-Marquardt; Florian Stengel; Martin Scheffner
Journal:  J Biol Chem       Date:  2020-08-27       Impact factor: 5.157

Review 5.  Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites.

Authors:  Vjekoslav Tomaić
Journal:  Cancers (Basel)       Date:  2016-10-19       Impact factor: 6.639

6.  Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.

Authors:  Andrea Cerasuolo; Clorinda Annunziata; Marianna Tortora; Noemy Starita; Giovanni Stellato; Stefano Greggi; Maria Grazia Maglione; Franco Ionna; Simona Losito; Gerardo Botti; Luigi Buonaguro; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Oncotarget       Date:  2017-05-23

Review 7.  PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6.

Authors:  Lennox Chitsike; Penelope J Duerksen-Hughes
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

8.  SOX2 as a New Regulator of HPV16 Transcription.

Authors:  Imelda Martínez-Ramírez; Víctor Del-Castillo-Falconi; Irma B Mitre-Aguilar; Alfredo Amador-Molina; Adela Carrillo-García; Elizabeth Langley; Alejandro Zentella-Dehesa; Ernesto Soto-Reyes; Alejandro García-Carrancá; Luis A Herrera; Marcela Lizano
Journal:  Viruses       Date:  2017-07-05       Impact factor: 5.048

9.  HPV11 E6 mutation by overexpression of APOBEC3A and effects of interferon-ω on APOBEC3s and HPV11 E6 expression in HPV11.HaCaT cells.

Authors:  Yongfang Wang; Xinyu Li; Shasha Song; Yang Sun; Jiafen Zhang; Changming Yu; Wei Chen
Journal:  Virol J       Date:  2017-11-03       Impact factor: 4.099

10.  HPV8-E6 Interferes with Syntenin-2 Expression through Deregulation of Differentiation, Methylation and Phosphatidylinositide-Kinase Dependent Mechanisms.

Authors:  Benjamin Marx; Daliborka Miller-Lazic; John Doorbar; Slawomir Majewski; Kay Hofmann; Martin Hufbauer; Baki Akgül
Journal:  Front Microbiol       Date:  2017-09-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.